Annual non current assets:
$19.10B+$5.50B(+40.42%)Summary
- As of today (June 26, 2025), REGN annual long term assets is $19.10 billion, with the most recent change of +$5.50 billion (+40.42%) on December 31, 2024.
- During the last 3 years, REGN annual non current assets has risen by +$7.68 billion (+67.24%).
- REGN annual non current assets is now at all-time high.
Performance
REGN Non current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly non current assets:
$19.97B+$875.00M(+4.58%)Summary
- As of today (June 26, 2025), REGN quarterly long term assets is $19.97 billion, with the most recent change of +$875.00 million (+4.58%) on March 31, 2025.
- Over the past year, REGN quarterly non current assets has increased by +$4.48 billion (+28.88%).
- REGN quarterly non current assets is now at all-time high.
Performance
REGN quarterly non current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Non current assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
REGN Non current assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +40.4% | +28.9% |
| 3 y3 years | +67.2% | +65.9% |
| 5 y5 years | +168.4% | +180.8% |
REGN Non current assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +67.2% | at high | +71.1% |
| 5 y | 5-year | at high | +168.4% | at high | +204.1% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
REGN Non current assets History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $19.97B(+4.6%) |
| Dec 2024 | $18.66B(-4.2%) | $19.10B(+5.5%) |
| Sep 2024 | - | $18.11B(+6.5%) |
| Jun 2024 | - | $17.01B(+9.7%) |
| Mar 2024 | - | $15.50B(+13.9%) |
| Dec 2023 | $19.48B(+22.6%) | $13.60B(+0.5%) |
| Sep 2023 | - | $13.53B(-1.5%) |
| Jun 2023 | - | $13.73B(+4.4%) |
| Mar 2023 | - | $13.15B(-1.3%) |
| Dec 2022 | $15.88B(+13.3%) | $13.33B(+8.8%) |
| Sep 2022 | - | $12.25B(+4.9%) |
| Jun 2022 | - | $11.68B(-3.0%) |
| Mar 2022 | - | $12.04B(+5.5%) |
| Dec 2021 | $14.01B(+43.3%) | $11.42B(+15.4%) |
| Sep 2021 | - | $9.90B(+21.4%) |
| Jun 2021 | - | $8.15B(+5.6%) |
| Mar 2021 | - | $7.72B(+4.5%) |
| Dec 2020 | $9.78B(+27.2%) | $7.38B(+5.7%) |
| Sep 2020 | - | $6.99B(+6.4%) |
| Jun 2020 | - | $6.57B(-7.7%) |
| Mar 2020 | - | $7.11B(-0.0%) |
| Dec 2019 | $7.69B(+19.3%) | $7.12B(+4.2%) |
| Sep 2019 | - | $6.83B(+4.7%) |
| Jun 2019 | - | $6.52B(+10.1%) |
| Mar 2019 | - | $5.93B(+12.1%) |
| Dec 2018 | $6.45B(+48.7%) | $5.29B(+3.9%) |
| Sep 2018 | - | $5.09B(-1.0%) |
| Jun 2018 | - | $5.14B(+6.4%) |
| Mar 2018 | - | $4.83B(+9.0%) |
| Dec 2017 | $4.33B(+36.3%) | $4.43B(-3.0%) |
| Sep 2017 | - | $4.57B(+7.5%) |
| Jun 2017 | - | $4.25B(+2.4%) |
| Mar 2017 | - | $4.15B(+9.4%) |
| Dec 2016 | $3.18B(+9.1%) | $3.79B(+14.0%) |
| Sep 2016 | - | $3.33B(+11.0%) |
| Jun 2016 | - | $3.00B(+8.1%) |
| Mar 2016 | - | $2.77B(+2.9%) |
| Dec 2015 | $2.92B(+39.8%) | $2.69B(+7.4%) |
| Sep 2015 | - | $2.51B(+11.8%) |
| Jun 2015 | - | $2.24B(+18.8%) |
| Mar 2015 | - | $1.89B(+7.7%) |
| Dec 2014 | $2.08B(+16.0%) | $1.75B(+13.9%) |
| Sep 2014 | - | $1.54B(+0.1%) |
| Jun 2014 | - | $1.54B(+10.7%) |
| Mar 2014 | - | $1.39B(+20.4%) |
| Dec 2013 | $1.80B(+49.0%) | $1.15B(+14.7%) |
| Sep 2013 | - | $1.01B(+23.2%) |
| Jun 2013 | - | $816.90M(-15.7%) |
| Mar 2013 | - | $968.88M(+10.8%) |
| Dec 2012 | $1.21B(+81.1%) | $874.48M(+22.8%) |
| Sep 2012 | - | $712.01M(+3.4%) |
| Jun 2012 | - | $688.31M(+5.4%) |
| Mar 2012 | - | $653.24M(-0.7%) |
| Dec 2011 | $665.78M(+86.2%) | $657.81M(+2.3%) |
| Sep 2011 | - | $643.16M(+1.5%) |
| Jun 2011 | - | $633.59M(-15.4%) |
| Mar 2011 | - | $748.79M(+2.3%) |
| Dec 2010 | $357.62M(-16.0%) | $731.81M(+99.6%) |
| Sep 2010 | - | $366.71M(-1.7%) |
| Jun 2010 | - | $372.89M(-4.8%) |
| Mar 2010 | - | $391.71M(+24.1%) |
| Dec 2009 | $425.51M(-18.4%) | $315.69M(+12.5%) |
| Sep 2009 | - | $280.60M(+1.2%) |
| Jun 2009 | - | $277.31M(+40.3%) |
| Mar 2009 | - | $197.63M(-2.5%) |
| Dec 2008 | $521.44M | $202.78M(+83.8%) |
| Sep 2008 | - | $110.35M(+1.4%) |
| Jun 2008 | - | $108.83M(-24.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $143.37M(+3.6%) |
| Dec 2007 | $797.83M(+69.8%) | $138.43M(-8.4%) |
| Sep 2007 | - | $151.08M(+49.8%) |
| Jun 2007 | - | $100.88M(-10.1%) |
| Mar 2007 | - | $112.27M(-2.5%) |
| Dec 2006 | $469.98M(+37.7%) | $115.11M(+41.3%) |
| Sep 2006 | - | $81.44M(-6.7%) |
| Jun 2006 | - | $87.28M(+5.9%) |
| Mar 2006 | - | $82.44M(+0.4%) |
| Dec 2005 | $341.39M(-0.7%) | $82.11M(-12.9%) |
| Sep 2005 | - | $94.32M(+7.6%) |
| Jun 2005 | - | $87.64M(-12.7%) |
| Mar 2005 | - | $100.44M(-22.2%) |
| Dec 2004 | $343.95M(+7.4%) | $129.15M(-20.0%) |
| Sep 2004 | - | $161.45M(+54.0%) |
| Jun 2004 | - | $104.84M(-7.9%) |
| Mar 2004 | - | $113.89M(-28.5%) |
| Dec 2003 | $320.21M(+15.6%) | $159.35M(+65.8%) |
| Sep 2003 | - | $96.12M(-4.3%) |
| Jun 2003 | - | $100.40M(-0.3%) |
| Mar 2003 | - | $100.70M(-12.1%) |
| Dec 2002 | $276.95M(-29.7%) | $114.63M(+9.4%) |
| Sep 2002 | - | $104.77M(-19.9%) |
| Jun 2002 | - | $130.75M(-3.0%) |
| Mar 2002 | - | $134.75M(+33.1%) |
| Dec 2001 | $394.19M(+193.9%) | $101.21M(+53.6%) |
| Sep 2001 | - | $65.89M(-21.1%) |
| Jun 2001 | - | $83.51M(+33.5%) |
| Mar 2001 | - | $62.55M(-15.6%) |
| Dec 2000 | $134.14M(+83.8%) | $74.13M(-6.5%) |
| Sep 2000 | - | $79.32M(+22.7%) |
| Jun 2000 | - | $64.65M(+10.4%) |
| Mar 2000 | - | $58.55M(-8.5%) |
| Dec 1999 | $73.00M(-21.4%) | $64.00M(+6.3%) |
| Sep 1999 | - | $60.20M(-5.3%) |
| Jun 1999 | - | $63.60M(-13.0%) |
| Mar 1999 | - | $73.10M(+14.2%) |
| Dec 1998 | $92.90M(-6.7%) | $64.00M(-12.6%) |
| Sep 1998 | - | $73.20M(-4.6%) |
| Jun 1998 | - | $76.70M(+8.8%) |
| Mar 1998 | - | $70.50M(+2.5%) |
| Dec 1997 | $99.60M(+17.2%) | $68.80M(+9.9%) |
| Sep 1997 | - | $62.60M(+5.4%) |
| Jun 1997 | - | $59.40M(+3.8%) |
| Mar 1997 | - | $57.20M(+8.7%) |
| Dec 1996 | $85.00M(+72.8%) | $52.60M(-8.0%) |
| Sep 1996 | - | $57.20M(-0.7%) |
| Jun 1996 | - | $57.60M(+20.8%) |
| Mar 1996 | - | $47.70M(+7.0%) |
| Dec 1995 | $49.20M(-5.4%) | $44.60M(+2.3%) |
| Sep 1995 | - | $43.60M(-0.7%) |
| Jun 1995 | - | $43.90M(-8.9%) |
| Mar 1995 | - | $48.20M(+14.2%) |
| Dec 1994 | $52.00M(-43.4%) | $42.20M(-16.3%) |
| Sep 1994 | - | $50.40M(0.0%) |
| Jun 1994 | - | $50.40M(-17.9%) |
| Mar 1994 | - | $61.40M(+138.0%) |
| Dec 1993 | $91.80M(+8.4%) | $25.80M(+58.3%) |
| Sep 1993 | - | $16.30M(+10.9%) |
| Jun 1993 | - | $14.70M(+6.5%) |
| Mar 1993 | - | $13.80M(+4.5%) |
| Dec 1992 | $84.70M(-20.5%) | $13.20M(+5.6%) |
| Sep 1992 | - | $12.50M(+10.6%) |
| Jun 1992 | - | $11.30M(+15.3%) |
| Mar 1992 | - | $9.80M(+32.4%) |
| Dec 1991 | $106.60M(+375.9%) | $7.40M(+68.2%) |
| Sep 1991 | - | $4.40M(+12.8%) |
| Jun 1991 | - | $3.90M(+30.0%) |
| Dec 1990 | $22.40M | $3.00M |
FAQ
- What is Regeneron Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual non current assets year-on-year change?
- What is Regeneron Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly non current assets year-on-year change?
What is Regeneron Pharmaceuticals annual long term assets?
The current annual non current assets of REGN is $19.10B
What is the all time high annual non current assets for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual long term assets is $19.10B
What is Regeneron Pharmaceuticals annual non current assets year-on-year change?
Over the past year, REGN annual long term assets has changed by +$5.50B (+40.42%)
What is Regeneron Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of REGN is $19.97B
What is the all time high quarterly non current assets for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly long term assets is $19.97B
What is Regeneron Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, REGN quarterly long term assets has changed by +$4.48B (+28.88%)